Showing results (1461-1470 of 5,607) with videos related to

Sort By:
Pageof 561
Nuclear Medicine Communications|October 19, 2001
A collimator with a magnetic personality?A N Priest, R W Barber
Nuclear Medicine Communications|April 30, 2003
Influence of diagnostic and therapeutic doses on thyroid remnant ablation ratesM Karam, A Gianoukakis, P J Feustel, et al.
Nuclear Medicine Communications|April 30, 2003
How 'hot' is the pathologically positive sentinel lymph node in breast cancer patients?P Bourgeois, J M Nogaret, I Veys, et al.
Nuclear Medicine Communications|April 30, 2003
Transient left ventricular dysfunction in ischaemic myocardium after stress: comparative study with exercise and pharmacological stress gated myocardial single photon emission computed tomographyY Iwado, H Furuyama, K Yoshinaga, et al.
Nuclear Medicine Communications|April 30, 2003
Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour modelsJ R Ballinger, V Hsue, A M Rauth
Nuclear Medicine Communications|May 1, 1992
A routine method for using sodium iodide to stabilize sodium pertechnetate [99Tcm] dispensed for the preparation of 99Tcm-exametazimeA M Millar
Nuclear Medicine Communications|July 1, 1992
The response of 99Tcm-methylene diphosphonate and 99Tcm-hexametazime-labelled neutrophils to intra-articular steroid injection in rheumatoid arthritisM A al-Janabi, R Sobnack, K K Solanki, et al.
Nuclear Medicine Communications|June 1, 1992
What proportion of isotope injected does the child receive in dynamic renal scanning?M A O'Reilly, I Gordon, H Thomas, et al.
Nuclear Medicine Communications|May 27, 2003
Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomographyL O Dierickx, H Everaert, P Deron, et al.
Nuclear Medicine Communications|May 27, 2003
188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritisE B Lee, K C Shin, Y J Lee, et al.
Pageof 561